Susquehanna International Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,500
Closed -$223K 13277
2025
Q4
$223K Sell
5,500
-1,300
-19% -$56.6K ﹤0.01% 10632
2025
Q3
$320K Buy
+6,800
New +$353K ﹤0.01% 9963
2024
Q4
Sell
-12,400
Closed -$892K 12309
2024
Q3
$892K Buy
+12,400
New +$875K ﹤0.01% 7063
2024
Q2
Sell
-21,600
Closed -$1.73M 12158
2024
Q1
$1.73M Buy
21,600
+5,700
+36% +$508K ﹤0.01% 5675
2023
Q4
$1.74M Sell
15,900
-25,000
-61% -$2.58M ﹤0.01% 5663
2023
Q3
$4.12M Buy
40,900
+2,100
+5% +$241K ﹤0.01% 3862
2023
Q2
$5.27M Buy
38,800
+31,700
+446% +$3.87M ﹤0.01% 3437
2023
Q1
$737K Sell
7,100
-51,100
-88% -$4.94M ﹤0.01% 7601
2022
Q4
$5.16M Buy
58,200
+50,700
+676% +$4.21M ﹤0.01% 3180
2022
Q3
$601K Buy
7,500
+4,600
+159% +$434K ﹤0.01% 7986
2022
Q2
$278K Buy
2,900
+600
+26% +$72K ﹤0.01% 9768
2022
Q1
$342K Sell
2,300
-4,700
-67% -$656K ﹤0.01% 9946
2021
Q4
$992K Buy
7,000
+3,900
+126% +$552K ﹤0.01% 7319
2021
Q3
$406K Buy
3,100
+1,100
+55% +$144K ﹤0.01% 9900
2021
Q2
$275K Sell
2,000
-9,600
-83% -$1.31M ﹤0.01% 10961
2021
Q1
$1.51M Sell
11,600
-2,400
-17% -$289K ﹤0.01% 6614
2020
Q4
$1.57M Sell
14,000
-22,000
-61% -$2.08M ﹤0.01% 5633
2020
Q3
$2.83M Buy
36,000
+20,600
+134% +$1.68M ﹤0.01% 3971
2020
Q2
$1.11M Buy
15,400
+3,900
+34% +$271K ﹤0.01% 5679
2020
Q1
$659K Buy
11,500
+9,200
+400% +$848K ﹤0.01% 6336
2019
Q4
$257K Sell
2,300
-16,400
-88% -$1.75M ﹤0.01% 8313
2019
Q3
$1.8M Buy
18,700
+5,400
+41% +$507K ﹤0.01% 4423
2019
Q2
$1.14M Buy
13,300
+9,400
+241% +$773K ﹤0.01% 5360
2019
Q1
$324K Buy
+3,900
New +$283K ﹤0.01% 7079
2018
Q3
Sell
-4,100
Closed -$300K 9299
2018
Q2
$300K Sell
4,100
-2,400
-37% -$163K ﹤0.01% 7847
2018
Q1
$412K Buy
+6,500
New +$388K ﹤0.01% 7022
2017
Q4
Sell
-7,200
Closed -$378K 9297
2017
Q3
$378K Buy
+7,200
New +$361K ﹤0.01% 7011
2017
Q2
Sell
-17,300
Closed -$768K 9244
2017
Q1
$768K Buy
17,300
+10,000
+137% +$430K ﹤0.01% 5673
2016
Q4
$322K Sell
7,300
-24,700
-77% -$1.05M ﹤0.01% 7833
2016
Q3
$1.28M Buy
32,000
+22,500
+237% +$955K ﹤0.01% 4333
2016
Q2
$453K Buy
+9,500
New +$402K ﹤0.01% 6292
2015
Q2
Sell
-6,500
Closed -$328K 10118
2015
Q1
$328K Sell
6,500
-3,700
-36% -$181K ﹤0.01% 7812
2014
Q4
$459K Sell
10,200
-3,800
-27% -$159K ﹤0.01% 7381
2014
Q3
$516K Buy
+14,000
New +$555K ﹤0.01% 7144
2013
Q3
Sell
-7,000
Closed -$219K 8414
2013
Q2
$219K Buy
+7,000
New +$227K ﹤0.01% 7299

Other funds holding CNMD

Susquehanna International Group's CNMD Position: Q1 2026 in Review

Susquehanna International Group increased its CONMED (CNMD) stake by 200% in Q1 2026, buying an estimated $880K and bringing the position to 32,452 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #7525.

Susquehanna International Group first reported a position in CNMD in Q4 2013 and has held it in 41 quarters since. The position peaked at $2.93M in Q4 2021. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Susquehanna International Group held 32,452 shares of CONMED worth $1.15M as of Q1 2026.
  • Susquehanna International Group bought 21,637 CONMED shares in Q1 2026, an estimated $880K.
  • CONMED made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7525 holding.
  • Susquehanna International Group first reported a position in CONMED in Q4 2013 and has held it in 41 quarters since.
  • Susquehanna International Group's CONMED position peaked at $2.93M in Q4 2021.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.